Advertisement

Topics

Argos Therapeutics Announces Appointment of Richard Morrison, PhD to Board of Directors

23:29 EDT 26 Sep 2017 | Topix

Argos Therapeutics Inc. , an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the ArcelisA precision immunotherapy technology platform, today announced the appointment of Richard Morrison, PhD, to the Company's board of directors. Dr. Morrison will serve as a Class III director and will serve on the audit committee of the board of directors.

Original Article: Argos Therapeutics Announces Appointment of Richard Morrison, PhD to Board of Directors

NEXT ARTICLE

More From BioPortfolio on "Argos Therapeutics Announces Appointment of Richard Morrison, PhD to Board of Directors"

Quick Search
Advertisement
 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...